Mesenchymal stem cell therapy for inflammatory bowel disease: A systematic review and meta-analysis

Maneesh Dave, Kathan Mehta, Jay Luther, Anushka Baruah, Allan B Dietz, William Alvis Faubion

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recent advances in inflammatory bowel disease (IBD) therapeutics include novel medical, surgical, and endoscopic treatments. Among these, stem cell therapy is still in its infancy, although multiple studies suggest that the immunomodulatory effect of stem cell therapy may reduce inflammation and tissue injury in patients with IBD. This review discusses the novel avenue of stem cell therapy and its potential role in the management of ulcerative colitis and Crohn's disease. We conducted a comprehensive literature search to identify studies examining the role of stem cell therapy (without conditioning and immunomodulatory regimens) in IBD. Taken together, these studies suggest a promising role for stem cell therapy in IBD although the substantial challenges, such as cost and inadequate/incomplete characterization of effect, limit their current use in clinical practice.

Original languageEnglish (US)
Pages (from-to)2696-2707
Number of pages12
JournalInflammatory Bowel Diseases
Volume21
Issue number11
DOIs
StatePublished - Jul 25 2015

Fingerprint

Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Inflammatory Bowel Diseases
Meta-Analysis
Stem Cells
Ulcerative Colitis
Crohn Disease
Inflammation
Costs and Cost Analysis
Wounds and Injuries
Therapeutics

Keywords

  • adverse effects
  • efficacy
  • inflammatory bowel disease
  • mesenchymal stem cells
  • systematic review and meta-analysis

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Mesenchymal stem cell therapy for inflammatory bowel disease : A systematic review and meta-analysis. / Dave, Maneesh; Mehta, Kathan; Luther, Jay; Baruah, Anushka; Dietz, Allan B; Faubion, William Alvis.

In: Inflammatory Bowel Diseases, Vol. 21, No. 11, 25.07.2015, p. 2696-2707.

Research output: Contribution to journalArticle

@article{97310b0256b1440ca9313deff44944b0,
title = "Mesenchymal stem cell therapy for inflammatory bowel disease: A systematic review and meta-analysis",
abstract = "Recent advances in inflammatory bowel disease (IBD) therapeutics include novel medical, surgical, and endoscopic treatments. Among these, stem cell therapy is still in its infancy, although multiple studies suggest that the immunomodulatory effect of stem cell therapy may reduce inflammation and tissue injury in patients with IBD. This review discusses the novel avenue of stem cell therapy and its potential role in the management of ulcerative colitis and Crohn's disease. We conducted a comprehensive literature search to identify studies examining the role of stem cell therapy (without conditioning and immunomodulatory regimens) in IBD. Taken together, these studies suggest a promising role for stem cell therapy in IBD although the substantial challenges, such as cost and inadequate/incomplete characterization of effect, limit their current use in clinical practice.",
keywords = "adverse effects, efficacy, inflammatory bowel disease, mesenchymal stem cells, systematic review and meta-analysis",
author = "Maneesh Dave and Kathan Mehta and Jay Luther and Anushka Baruah and Dietz, {Allan B} and Faubion, {William Alvis}",
year = "2015",
month = "7",
day = "25",
doi = "10.1097/MIB.0000000000000543",
language = "English (US)",
volume = "21",
pages = "2696--2707",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Mesenchymal stem cell therapy for inflammatory bowel disease

T2 - A systematic review and meta-analysis

AU - Dave, Maneesh

AU - Mehta, Kathan

AU - Luther, Jay

AU - Baruah, Anushka

AU - Dietz, Allan B

AU - Faubion, William Alvis

PY - 2015/7/25

Y1 - 2015/7/25

N2 - Recent advances in inflammatory bowel disease (IBD) therapeutics include novel medical, surgical, and endoscopic treatments. Among these, stem cell therapy is still in its infancy, although multiple studies suggest that the immunomodulatory effect of stem cell therapy may reduce inflammation and tissue injury in patients with IBD. This review discusses the novel avenue of stem cell therapy and its potential role in the management of ulcerative colitis and Crohn's disease. We conducted a comprehensive literature search to identify studies examining the role of stem cell therapy (without conditioning and immunomodulatory regimens) in IBD. Taken together, these studies suggest a promising role for stem cell therapy in IBD although the substantial challenges, such as cost and inadequate/incomplete characterization of effect, limit their current use in clinical practice.

AB - Recent advances in inflammatory bowel disease (IBD) therapeutics include novel medical, surgical, and endoscopic treatments. Among these, stem cell therapy is still in its infancy, although multiple studies suggest that the immunomodulatory effect of stem cell therapy may reduce inflammation and tissue injury in patients with IBD. This review discusses the novel avenue of stem cell therapy and its potential role in the management of ulcerative colitis and Crohn's disease. We conducted a comprehensive literature search to identify studies examining the role of stem cell therapy (without conditioning and immunomodulatory regimens) in IBD. Taken together, these studies suggest a promising role for stem cell therapy in IBD although the substantial challenges, such as cost and inadequate/incomplete characterization of effect, limit their current use in clinical practice.

KW - adverse effects

KW - efficacy

KW - inflammatory bowel disease

KW - mesenchymal stem cells

KW - systematic review and meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=84945249500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945249500&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000543

DO - 10.1097/MIB.0000000000000543

M3 - Article

VL - 21

SP - 2696

EP - 2707

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 11

ER -